Literature DB >> 20920431

Novel use of platelet-rich plasma to augment curative diabetic foot surgery.

Christy L Scimeca1, Manish Bharara, Timothy K Fisher, Heather Kimbriel, David G Armstrong.   

Abstract

Autologous platelet-rich plasma (PRP) may enhance wound healing through the formation of a platelet plug that provides both hemostasis and the secretion of biologically active proteins, including growth factors such as platelet-derived growth factor, transforming growth factor (TGF)-β, TGF-β2, and epidermal growth factor. The release of these growth factors into the wound may create an environment more conducive to tissue repair and could accelerate postoperative wound healing. To our knowledge, there are no reports of combining the use of PRP with curative diabetic foot surgery. This article provides a summary of the literature regarding PRP and wound healing and presents a case of a 49-year-old man with diabetes and a three-month history of a deep, nonhealing plantar hallux wound in which PRP was combined with a first metatarsophalangeal joint arthroplasty. Through the use of the PRP and bioengineered tissue to supplement curative diabetic foot surgery, the patient healed uneventfully at seven weeks.
© 2010 Diabetes Technology Society.

Entities:  

Mesh:

Year:  2010        PMID: 20920431      PMCID: PMC2956802          DOI: 10.1177/193229681000400510

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  46 in total

1.  Platelet-rich plasma (PRP): what is PRP and what is not PRP?

Authors:  R E Marx
Journal:  Implant Dent       Date:  2001       Impact factor: 2.454

Review 2.  Autologous platelets as a source of proteins for healing and tissue regeneration.

Authors:  Eduardo Anitua; Isabel Andia; Bruno Ardanza; Paquita Nurden; Alan T Nurden
Journal:  Thromb Haemost       Date:  2004-01       Impact factor: 5.249

3.  Molecular and mechanistic validation of delayed healing rat wounds as a model for human chronic wounds.

Authors:  C Chen; G S Schultz; M Bloch; P D Edwards; S Tebes; B A Mast
Journal:  Wound Repair Regen       Date:  1999 Nov-Dec       Impact factor: 3.617

Review 4.  Physiology of the chronic wound.

Authors:  B C Nwomeh; D R Yager; I K Cohen
Journal:  Clin Plast Surg       Date:  1998-07       Impact factor: 2.017

5.  Platelet-rich plasma: Growth factor enhancement for bone grafts.

Authors:  R E Marx; E R Carlson; R M Eichstaedt; S R Schimmele; J E Strauss; K R Georgeff
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1998-06

Review 6.  Platelet-derived growth factor.

Authors:  R Ross
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

7.  Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies.

Authors:  J M Smiell; T J Wieman; D L Steed; B H Perry; A R Sampson; B H Schwab
Journal:  Wound Repair Regen       Date:  1999 Sep-Oct       Impact factor: 3.617

8.  Peak foot pressures influence the healing time of diabetic foot ulcers treated with total contact casts.

Authors:  D G Armstrong; L A Lavery; T R Bushman
Journal:  J Rehabil Res Dev       Date:  1998-01

9.  Wound healing angiogenesis: indirect stimulation by basic fibroblast growth factor.

Authors:  D R Knighton; G D Phillips; V D Fiegel
Journal:  J Trauma       Date:  1990-12

10.  Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF).

Authors:  D R Knighton; K F Ciresi; V D Fiegel; L L Austin; E L Butler
Journal:  Ann Surg       Date:  1986-09       Impact factor: 12.969

View more
  5 in total

Review 1.  The use of fat grafting and platelet-rich plasma for wound healing: A review of the current evidence.

Authors:  Oliver J Smith; Gavin Jell; Ash Mosahebi
Journal:  Int Wound J       Date:  2018-11-20       Impact factor: 3.315

2.  Autologous derived, platelet-rich plasma gel in the treatment of nonhealing diabetic foot ulcer: a case report.

Authors:  Torsten Slesaczeck; Hartmut Paetzold; Thomas Nanning; Andreas Reichel; Andreas Barthel; Stefan Bornstein; Matthias Weck
Journal:  Ther Adv Endocrinol Metab       Date:  2012-04       Impact factor: 3.565

3.  Effectiveness of Injected Platelet-Rich Plasma in the Treatment of Diabetic Foot Ulcer Disease.

Authors:  Asad Ullah; Syed I Jawaid; Pir Naveed Ahmed Ahsan Qureshi; Tehreem Siddiqui; Khadija Nasim; Kantash Kumar; Shafqat Ullah; Mustafa Sajjad Cheema; Nikita Kumari; Hafiza Azad Elias
Journal:  Cureus       Date:  2022-08-23

4.  Soft Tissue Augmentation with Autologous Platelet Gel and β-TCP: A Histologic and Histometric Study in Mice.

Authors:  Antonio Scarano; Maurizio Ceccarelli; Massimiliano Marchetti; Adriano Piattelli; Carmen Mortellaro
Journal:  Biomed Res Int       Date:  2016-07-12       Impact factor: 3.411

5.  Adjunct methods of the standard diabetic foot ulceration therapy.

Authors:  Dariusz Waniczek; Andrzej Kozowicz; Małgorzata Muc-Wierzgoń; Teresa Kokot; Elżbieta Swiętochowska; Ewa Nowakowska-Zajdel
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-13       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.